Matches in SemOpenAlex for { <https://semopenalex.org/work/W2263343313> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2263343313 endingPage "501" @default.
- W2263343313 startingPage "494" @default.
- W2263343313 abstract "Anaemia is a frequent finding in patients with cancer and may be due to different causes, including blunted erythropoietin production.In a pilot study, we administered recombinant human erythropoietin (rHuEPO) to twelve patients with solid tumours and secondary anaemia. rHuEPO was given subcutaneously 5 d per week at escalating doses (75 to 150 U/kg per day): the aim of treatment was a Hb level > or = 10 g/dl without blood transfusion. We evaluated endogenous EPO production through serum EPO levels and erythroid marrow activity by means of serum transferrin receptor (TfR).Six out of 12 subjects had defective endogenous EPO production. All patients but two responded to treatment with steady increases in Hb levels above 10 g/dl, and the median dose of rHuEPO required for correction of anaemia was 75 U/kg. Response was associated with an early increase in serum TfR. Six patients developed functional iron deficiency and required iron supplementation to obtain response. Treatment improved functional ability in 4/10 responders.Subcutaneous rHuEPO can stimulate erythroid marrow activity in cancer anaemia, even in patients with advanced disease, and marrow response can be adequately monitored by serum TfR. Functional iron deficiency as a cause of nonresponse to rHuEPO is frequent in these patients and may require parenteral iron administration. Although erythropoietin can improve the anaemia of cancer, the decision to treat should be individualised for each patient, looking more at the quality of life and cost-effectiveness than at cosmetic increases in the haemoglobin level." @default.
- W2263343313 created "2016-06-24" @default.
- W2263343313 creator A5004723056 @default.
- W2263343313 creator A5017870467 @default.
- W2263343313 creator A5019241495 @default.
- W2263343313 creator A5019747776 @default.
- W2263343313 creator A5022543525 @default.
- W2263343313 creator A5047671479 @default.
- W2263343313 creator A5050011235 @default.
- W2263343313 creator A5050692336 @default.
- W2263343313 creator A5065961744 @default.
- W2263343313 creator A5078632311 @default.
- W2263343313 date "1992-11-01" @default.
- W2263343313 modified "2023-09-27" @default.
- W2263343313 title "Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia." @default.
- W2263343313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1289186" @default.
- W2263343313 hasPublicationYear "1992" @default.
- W2263343313 type Work @default.
- W2263343313 sameAs 2263343313 @default.
- W2263343313 citedByCount "13" @default.
- W2263343313 crossrefType "journal-article" @default.
- W2263343313 hasAuthorship W2263343313A5004723056 @default.
- W2263343313 hasAuthorship W2263343313A5017870467 @default.
- W2263343313 hasAuthorship W2263343313A5019241495 @default.
- W2263343313 hasAuthorship W2263343313A5019747776 @default.
- W2263343313 hasAuthorship W2263343313A5022543525 @default.
- W2263343313 hasAuthorship W2263343313A5047671479 @default.
- W2263343313 hasAuthorship W2263343313A5050011235 @default.
- W2263343313 hasAuthorship W2263343313A5050692336 @default.
- W2263343313 hasAuthorship W2263343313A5065961744 @default.
- W2263343313 hasAuthorship W2263343313A5078632311 @default.
- W2263343313 hasConcept C121608353 @default.
- W2263343313 hasConcept C126322002 @default.
- W2263343313 hasConcept C203014093 @default.
- W2263343313 hasConcept C2776485076 @default.
- W2263343313 hasConcept C2777417653 @default.
- W2263343313 hasConcept C2778248108 @default.
- W2263343313 hasConcept C2778534260 @default.
- W2263343313 hasConcept C2779703530 @default.
- W2263343313 hasConcept C2780007613 @default.
- W2263343313 hasConcept C3019673199 @default.
- W2263343313 hasConcept C71924100 @default.
- W2263343313 hasConcept C90924648 @default.
- W2263343313 hasConceptScore W2263343313C121608353 @default.
- W2263343313 hasConceptScore W2263343313C126322002 @default.
- W2263343313 hasConceptScore W2263343313C203014093 @default.
- W2263343313 hasConceptScore W2263343313C2776485076 @default.
- W2263343313 hasConceptScore W2263343313C2777417653 @default.
- W2263343313 hasConceptScore W2263343313C2778248108 @default.
- W2263343313 hasConceptScore W2263343313C2778534260 @default.
- W2263343313 hasConceptScore W2263343313C2779703530 @default.
- W2263343313 hasConceptScore W2263343313C2780007613 @default.
- W2263343313 hasConceptScore W2263343313C3019673199 @default.
- W2263343313 hasConceptScore W2263343313C71924100 @default.
- W2263343313 hasConceptScore W2263343313C90924648 @default.
- W2263343313 hasIssue "6" @default.
- W2263343313 hasLocation W22633433131 @default.
- W2263343313 hasOpenAccess W2263343313 @default.
- W2263343313 hasPrimaryLocation W22633433131 @default.
- W2263343313 hasRelatedWork W180291700 @default.
- W2263343313 hasRelatedWork W1987127657 @default.
- W2263343313 hasRelatedWork W2001038311 @default.
- W2263343313 hasRelatedWork W2049690918 @default.
- W2263343313 hasRelatedWork W2412147442 @default.
- W2263343313 hasRelatedWork W2418153023 @default.
- W2263343313 hasRelatedWork W4211235902 @default.
- W2263343313 hasRelatedWork W4240369490 @default.
- W2263343313 hasRelatedWork W85672453 @default.
- W2263343313 hasRelatedWork W53896844 @default.
- W2263343313 hasVolume "77" @default.
- W2263343313 isParatext "false" @default.
- W2263343313 isRetracted "false" @default.
- W2263343313 magId "2263343313" @default.
- W2263343313 workType "article" @default.